Despite activating the same pathway, mutations in Pik3ca and inactivation of PTEN are associated with overlapping but distinct tumour profiles and have different outcomes, both in the clinic and in mouse models of cancer6, 11. This evidence concerns the gene PTEN and neoplasm.